BUSINESS Johnson & Johnson, Risperdal maker hit with $8B verdict

BUSINESS

Johnson & Johnson, Risperdal maker hit with $8B verdict

AP

08:34, October 09, 2019

A Philadelphia jury has decided that Johnson & Johnson and Janssen Pharmaceuticals should pay $8 billion over an antipsychotic drug linked to the abnormal growth of female breast tissue in boys.

AP_19281844667899_副本.jpg

File photo: AP

A law firm for the plaintiff released a statement Tuesday saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal.

Johnson & Johnson says the jury's award "is grossly disproportionate with the initial compensatory award in this case," and that the company is "confident it will be overturned."

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue